Ygierne Dodoo

A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients

S. Goldman, P. Coulie, M. Toungouz, 2006, Cancer Immunology, Immunotherapy.